drugset / Trial / NCT04749914
A Study of Lasmiditan in Healthy Volunteers
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The main purpose of the study is to investigate the blood concentrations of dabigatran etexilate and rosuvastatin when taken alone compared to when taken together with lasmiditan in healthy participants. The safety and tolerability of dabigatran etexilate or rosuvastatin in combination with lasmiditan will also be evaluated in healthy participants. The study has two parts. Each part will last up to 17 days, not including screening.
Timeline
- Start
- 2021-02-15
- Primary completion
- 2021-07-06
- Completion
- 2021-07-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | Oral |
| Subject | Lasmiditan | Small molecule | 200 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |
Indications
No indication recorded.